Clinical evaluation and safety of loxiglumide (CCK-A receptor antagonist) in nonresectable pancreatic cancer patients. Italian Pancreatic Cancer Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples